Search Results
Sep 03, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Aug 27, 2026, 18:11 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims
Behalf of Investors of CVRx, Inc. - CVRXNEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised
More news about: Pomerantz LLP
Aug 26, 2026, 13:08 ET HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages CVRx Inc. (CVRX) Investors with Substantial Losses to Contact Firm: Investigating Potential Securities Fraud Following 59% Stock Drop
Kathrein, the Hagens Berman partner leading the firm's investigation.WHAT CVRx (CVRX) INVESTORS & WHISTLEBLOWERS CAN DOInvestors: If you invested in CVRx, Inc. (NASDAQ: CVRX) and suffered significant financial losses, you can
More news about: Hagens Berman Sobol Shapiro LLP
Aug 24, 2026, 08:30 ET Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer
Founder of Pointillist Family Office and beneficial owner of more than 5.5% of the outstanding shares of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRx), today delivered a letter to the CVRx Board of Directors (the "Board"), urging it to launch an immediate and formal process to sell the Company
More news about: Jorey Chernett
Aug 19, 2026, 16:23 ET HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages CVRx Inc. (CVRX) Investors with Substantial Losses to Contact Firm: Investigating Potential Securities Fraud Following 59% Stock Drop
www.hbsslaw.com/cases/cvrxINVESTIGATION OVERVIEW: CVRx Inc. (NASDAQ: CVRX)CVRx's sole commercial product is Barostim, an FDA-approved implantable neuromodulation device designed to improve symptoms for patients suffering from heart failure. Historically, CVRx assured
More news about: Hagens Berman Sobol Shapiro LLP
Aug 14, 2026, 15:42 ET HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages CVRx Inc. (CVRX) Investors with Substantial Losses to Contact Firm: Investigating Potential Securities Fraud Following 59% Stock Drop
Kathrein, the Hagens Berman partner leading the firm's investigation.WHAT CVRx (CVRX) INVESTORS & WHISTLEBLOWERS CAN DOInvestors: If you invested in CVRx, Inc. (NASDAQ: CVRX) and suffered significant financial losses, you can
More news about: Hagens Berman Sobol Shapiro LLP
Feb 26, 2026, 15:12 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
Feb. 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Feb 19, 2026, 20:06 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
Feb. 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Feb 12, 2026, 18:51 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
Feb. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jan 29, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRX
Jan. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Jan 09, 2026, 13:27 ET Ventaris Surgical, Inc. Announces $30M Series A to Advance a Next-Generation System for Complete Kidney Stone Treatment
of successfully partnering with entrepreneurs behind industry-leading companies, including Artelon, Cameron Health, CardiAQ, Cartiva, CV Ingenuity, CVRx, Epix Therapeutics, Inari Medical, Intact Vascular, Lutonix, Neuwave Medical, Personal Genome Diagnostics, Relievant Medsystems, Sequent Medical, Topera,
More news about: Ventaris Surgical, Inc.
Nov 04, 2025, 15:17 ET Emergent Software Celebrates 10 Years of Empowering Growth Through Microsoft-Centric Technology Solutions
"Emergent didn't just build our portal — they helped us shape the strategy behind it," said Rick Mueller, IT Director at CVRx. "They're the kind of partner you want when you're bringing something entirely new to market." "Emergent helped us move
More news about: Emergent Software